# Pediatrix Medical Group, Inc.: filings

MD · NYSE · CIK 893949 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/md.md) · [Financials](/companies/md/financials.md) · [Filings](/companies/md/filings.md) · [Insiders](/companies/md/insiders.md)

## Reports and events: 259 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 543, 8-K 156, SC 13G/A 61, 10-Q 54, 3 27, 144 23, DEFA14A 23, DEF 14A 19, 10-K 18, SC 13G 17, UPLOAD 16, CORRESP 14, ARS 10, SC 13D/A 7, S-8 6, 4/A 5, S-8 POS 5, SCHEDULE 13G/A 5, D 4, 5 3, SCHEDULE 13G 3, SC 13D 2, SEC STAFF LETTER 2, 10-K/A 1, 10-Q/A 1, 15-12B 1, 25-NSE 1, 8-K12B 1, 8-K/A 1, CT ORDER 1, DFAN14A 1, PRE 14A 1, S-3ASR 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 07:00 ET | [10-Q](/filings/0001193125-26-436952.md) | Quarterly report, period 2026-09-30 | 0001193125-26-436952 |
| 2026-10-29 | 06:50 ET | [8-K](/filings/0001193125-26-436932.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-436932 |
| 2026-08-04 | 07:00 ET | [10-Q](/filings/0001193125-26-331513.md) | Quarterly report, period 2026-06-30 | 0001193125-26-331513 |
| 2026-08-04 | 06:50 ET | [8-K](/filings/0001193125-26-331488.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-331488 |
| 2026-07-24 | 17:00 ET | [8-K](/filings/0001193125-26-316225.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure | 0001193125-26-316225 |
| 2026-07-15 | 07:00 ET | [8-K](/filings/0001193125-26-304033.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-304033 |
| 2026-05-07 | 16:30 ET | [8-K](/filings/0001193125-26-212117.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-212117 |
| 2026-05-05 | 07:00 ET | [10-Q](/filings/0001193125-26-204993.md) | Quarterly report, period 2026-03-31 | 0001193125-26-204993 |
| 2026-05-05 | 06:50 ET | [8-K](/filings/0001193125-26-204982.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-204982 |
| 2026-03-27 | 06:50 ET | [DEF 14A](/filings/0001193125-26-127299.md) | Proxy statement, period 2026-03-25 | 0001193125-26-127299 |
| 2026-02-19 | 07:00 ET | [10-K](/filings/0001193125-26-058074.md) | Annual report, period 2025-12-31 | 0001193125-26-058074 |
| 2026-02-19 | 06:50 ET | [8-K](/filings/0001193125-26-058063.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-058063 |
| 2025-11-03 | 07:00 ET | [10-Q](/filings/0001193125-25-261640.md) | Quarterly report, period 2025-09-30 | 0001193125-25-261640 |
| 2025-11-03 | 06:50 ET | [8-K](/filings/0001193125-25-261626.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-261626 |
| 2025-08-18 | 16:45 ET | [8-K](/filings/0000950170-25-109777.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-109777 |
| 2025-08-05 | 07:00 ET | [10-Q](/filings/0000950170-25-102382.md) | Quarterly report, period 2025-06-30 | 0000950170-25-102382 |
| 2025-08-05 | 06:50 ET | [8-K](/filings/0000950170-25-102375.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-102375 |
| 2025-07-01 | 16:30 ET | [8-K](/filings/0000950170-25-092261.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-092261 |
| 2025-05-08 | 16:30 ET | [8-K](/filings/0000950170-25-067076.md) | 5.07 Shareholder vote results | 0000950170-25-067076 |
| 2025-05-06 | 07:00 ET | [10-Q](/filings/0000950170-25-063951.md) | Quarterly report, period 2025-03-31 | 0000950170-25-063951 |
| 2025-05-06 | 06:50 ET | [8-K](/filings/0000950170-25-063946.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-063946 |
| 2025-04-18 | 16:30 ET | [8-K](/filings/0000950170-25-055880.md) | 1.01 Entry into a material agreement | 0000950170-25-055880 |
| 2025-03-28 | 06:52 ET | [DEF 14A](/filings/0000950170-25-046327.md) | Proxy statement, period 2025-03-26 | 0000950170-25-046327 |
| 2025-02-20 | 07:00 ET | [10-K](/filings/0000950170-25-023730.md) | Annual report, period 2024-12-31 | 0000950170-25-023730 |
| 2025-02-20 | 06:50 ET | [8-K](/filings/0000950170-25-023723.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-023723 |
| 2025-01-14 | 16:30 ET | [8-K](/filings/0001193125-25-006190.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-006190 |
| 2025-01-13 | 06:50 ET | [8-K](/filings/0001193125-25-004937.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-004937 |
| 2024-12-05 | 16:30 ET | [8-K](/filings/0000950170-24-133723.md) | 5.02 Departure or appointment of officers or directors | 0000950170-24-133723 |
| 2024-11-01 | 07:00 ET | [10-Q](/filings/0000950170-24-119796.md) | Quarterly report, period 2024-09-30 | 0000950170-24-119796 |
| 2024-11-01 | 06:50 ET | [8-K](/filings/0000950170-24-119795.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-119795 |
| 2024-08-06 | 07:00 ET | [10-Q](/filings/0000950170-24-091193.md) | Quarterly report, period 2024-06-30 | 0000950170-24-091193 |
| 2024-08-06 | 06:50 ET | [8-K](/filings/0000950170-24-091185.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-091185 |
| 2024-06-17 | 16:30 ET | [8-K](/filings/0000950170-24-074283.md) | 5.02 Departure or appointment of officers or directors | 0000950170-24-074283 |
| 2024-05-30 | 06:50 ET | [8-K](/filings/0000950170-24-066242.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-066242 |
| 2024-05-09 | 16:30 ET | [8-K](/filings/0000950170-24-057093.md) | 5.07 Shareholder vote results | 0000950170-24-057093 |
| 2024-05-07 | 07:03 ET | [10-Q](/filings/0000950170-24-053922.md) | Quarterly report, period 2024-03-31 | 0000950170-24-053922 |
| 2024-05-07 | 06:50 ET | [8-K](/filings/0000950170-24-053917.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-053917 |
| 2024-04-25 | 16:31 ET | [8-K](/filings/0000950170-24-048387.md) | 1.01 Entry into a material agreement | 0000950170-24-048387 |
| 2024-03-28 | 06:50 ET | [DEF 14A](/filings/0001193125-24-079571.md) | Proxy statement, period 2024-05-09 | 0001193125-24-079571 |
| 2024-02-20 | 07:00 ET | [10-K](/filings/0000950170-24-016794.md) | Annual report, period 2023-12-31 | 0000950170-24-016794 |
| 2024-02-20 | 06:50 ET | [8-K](/filings/0000950170-24-016790.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-016790 |
| 2023-11-02 | 07:00 ET | [10-Q](/filings/0000950170-23-057738.md) | Quarterly report, period 2023-09-30 | 0000950170-23-057738 |
| 2023-11-02 | 06:50 ET | [8-K](/filings/0000950170-23-057732.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-057732 |
| 2023-08-03 | 07:01 ET | [10-Q](/filings/0000950170-23-037565.md) | Quarterly report, period 2023-06-30 | 0000950170-23-037565 |
| 2023-08-03 | 06:50 ET | [8-K](/filings/0000950170-23-037559.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-037559 |
| 2023-05-11 | 16:35 ET | [8-K](/filings/0000950170-23-021326.md) | 5.07 Shareholder vote results | 0000950170-23-021326 |
| 2023-05-04 | 16:16 ET | [8-K](/filings/0000950170-23-017882.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-017882 |
| 2023-05-02 | 07:01 ET | [10-Q](/filings/0000950170-23-016430.md) | Quarterly report, period 2023-03-31 | 0000950170-23-016430 |
| 2023-05-02 | 06:50 ET | [8-K](/filings/0000950170-23-016427.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-016427 |
| 2023-03-31 | 07:06 ET | [DEF 14A](/filings/0001193125-23-086703.md) | Proxy statement | 0001193125-23-086703 |

Page 1 of 6. [Older](/companies/md/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 07:14 ET. No prices; not investment advice.